Search - tctmd.com

Displaying 21 - 34 of 34

Sort: Relevancy | Date

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

January 24, 2023

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

December 02, 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

November 07, 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

November 04, 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

August 30, 2022

August 2022 News Roundup

News Opinion CV Team Dispatch

August 2022 News Roundup

August 01, 2022

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

June 01, 2022

Statins Underprescribed in PAD Before and After Interventions

News Daily News

Statins Underprescribed in PAD Before and After Interventions

December 03, 2021

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

April 02, 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

March 28, 2020

Outcome Differences Between Men and Women With PAD: EUCLID Insights

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

February 11, 2020

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

News Daily News

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

September 16, 2019

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

November 15, 2018

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

December 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.